Alexion, AstraZeneca Rare Disease was created following the 2021 acquisition of Alexion Pharmaceuticals, Inc. by AstraZeneca. For more than 30 years, Alexion’s mission has been to transform the lives of people affected by rare diseases through the development and delivery of innovative medicines, su...See more
Headquarter United States of America |
Countries of operation Australia, Indonesia, Philippines, ... See more |
Year founded 1992 (32 years) |
Funding status Publicly listed on stock exchange |
Company type MNC / Large Enterprise |
EA to GM & Commercial Administration Partner
Head of Finance - ANZ & China
Head of Country Operations, Australia and New Zealand
Job title | Name | Email | Country based in | Job Function | Seniority | |
---|---|---|---|---|---|---|
EA to GM & Commercial Administration Partner | hidden.item | hidden.item | hidden.item | |||
Head of Finance - ANZ & China | hidden.item | hidden.item | hidden.item | |||
Head of Country Operations, Australia and New Zealand | hidden.item | hidden.item | hidden.item |